147 related articles for article (PubMed ID: 21469528)
1. Müller glial cells--the mediators of vascular disorders with vitreomacular interface pathology in diabetic maculopathy.
Robaszkiewicz J; Chmielewska K; Figurska M; Wierzbowska J; Stankiewicz A
Klin Oczna; 2010; 112(10-12):328-32. PubMed ID: 21469528
[TBL] [Abstract][Full Text] [Related]
2. Epiretinal pathology of diffuse diabetic macular edema associated with vitreomacular traction.
Gandorfer A; Rohleder M; Grosselfinger S; Haritoglou C; Ulbig M; Kampik A
Am J Ophthalmol; 2005 Apr; 139(4):638-52. PubMed ID: 15808159
[TBL] [Abstract][Full Text] [Related]
3. Conditional Müllercell ablation causes independent neuronal and vascular pathologies in a novel transgenic model.
Shen W; Fruttiger M; Zhu L; Chung SH; Barnett NL; Kirk JK; Lee S; Coorey NJ; Killingsworth M; Sherman LS; Gillies MC
J Neurosci; 2012 Nov; 32(45):15715-27. PubMed ID: 23136411
[TBL] [Abstract][Full Text] [Related]
4. [Role of the retinal pigment epithelium (RPE) in the pathogenesis and treatment of diabetic macular edema (DME)].
Chmielewska K; Robaszkiewicz J; Kosatka M
Klin Oczna; 2008; 110(7-9):318-20. PubMed ID: 19112870
[TBL] [Abstract][Full Text] [Related]
5. Pigment epithelium-derived factor acts as an opponent of growth-stimulatory factors in retinal glial-endothelial cell interactions.
Yafai Y; Lange J; Wiedemann P; Reichenbach A; Eichler W
Glia; 2007 Apr; 55(6):642-51. PubMed ID: 17309061
[TBL] [Abstract][Full Text] [Related]
6. PEDF derived from glial Müller cells: a possible regulator of retinal angiogenesis.
Eichler W; Yafai Y; Keller T; Wiedemann P; Reichenbach A
Exp Cell Res; 2004 Sep; 299(1):68-78. PubMed ID: 15302574
[TBL] [Abstract][Full Text] [Related]
7. Epiretinal cell proliferation in macular pucker and vitreomacular traction syndrome: analysis of flat-mounted internal limiting membrane specimens.
Zhao F; Gandorfer A; Haritoglou C; Scheler R; Schaumberger MM; Kampik A; Schumann RG
Retina; 2013 Jan; 33(1):77-88. PubMed ID: 22914684
[TBL] [Abstract][Full Text] [Related]
8. Diffuse diabetic macular edema: pathology and implications for surgery.
Gandorfer A
Dev Ophthalmol; 2007; 39():88-95. PubMed ID: 17245080
[TBL] [Abstract][Full Text] [Related]
9. Vitrectomy for Diabetic Macular Edema: Optical Coherence Tomography Criteria and Pathology of the Vitreomacular Interface.
Hagenau F; Vogt D; Ziada J; Guenther SR; Haritoglou C; Wolf A; Priglinger SG; Schumann RG
Am J Ophthalmol; 2019 Apr; 200():34-46. PubMed ID: 30557531
[TBL] [Abstract][Full Text] [Related]
10. Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles.
Patel JI; Tombran-Tink J; Hykin PG; Gregor ZJ; Cree IA
Exp Eye Res; 2006 May; 82(5):798-806. PubMed ID: 16324700
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of the protein pattern in physiologic and pathologic vitreous bodies by electrophoresis and immunologic identification].
Bresgen M; Martiny B; Weller M; Heimann K; Wiedemann P
Fortschr Ophthalmol; 1991; 88(6):665-70. PubMed ID: 1794787
[TBL] [Abstract][Full Text] [Related]
12. [Relationship between vitrectomy and the morphology and function of the retina].
Terasaki H
Nippon Ganka Gakkai Zasshi; 2003 Dec; 107(12):836-64; discussion 865. PubMed ID: 14733133
[TBL] [Abstract][Full Text] [Related]
13. Pigment epithelium-derived factor inhibits retinal microvascular dysfunction induced by 12/15-lipoxygenase-derived eicosanoids.
Ibrahim AS; Tawfik AM; Hussein KA; Elshafey S; Markand S; Rizk N; Duh EJ; Smith SB; Al-Shabrawey M
Biochim Biophys Acta; 2015 Mar; 1851(3):290-8. PubMed ID: 25562624
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of blood-retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy.
Wisniewska-Kruk J; Klaassen I; Vogels IM; Magno AL; Lai CM; Van Noorden CJ; Schlingemann RO; Rakoczy EP
Exp Eye Res; 2014 May; 122():123-31. PubMed ID: 24703908
[TBL] [Abstract][Full Text] [Related]
15. Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy.
Ogata N; Nishikawa M; Nishimura T; Mitsuma Y; Matsumura M
Am J Ophthalmol; 2002 Sep; 134(3):348-53. PubMed ID: 12208245
[TBL] [Abstract][Full Text] [Related]
16. The pathogenesis of edema in diabetic maculopathy.
Antcliff RJ; Marshall J
Semin Ophthalmol; 1999 Dec; 14(4):223-32. PubMed ID: 10758223
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy.
Amin RH; Frank RN; Kennedy A; Eliott D; Puklin JE; Abrams GW
Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):36-47. PubMed ID: 9008628
[TBL] [Abstract][Full Text] [Related]
18. Pathological changes in the vitreoretinal junction 1: epiretinal membrane formation.
Snead DR; James S; Snead MP
Eye (Lond); 2008 Oct; 22(10):1310-7. PubMed ID: 18344963
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of maculopathy.
Eagle RC
Ophthalmology; 1984 Jun; 91(6):613-25. PubMed ID: 6205340
[TBL] [Abstract][Full Text] [Related]
20. Regulation of pigment epithelium-derived factor production and release by retinal glial (Müller) cells under hypoxia.
Lange J; Yafai Y; Reichenbach A; Wiedemann P; Eichler W
Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):5161-7. PubMed ID: 18676622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
